<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85436-002-02
</NDCCode>
<PackageDescription>
20 VIAL in 1 BOX (85436-002-02) / 15 mg in 1 VIAL
</PackageDescription>
<NDC11Code>
85436-0002-02
</NDC11Code>
<ProductNDC>
85436-002
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Nasocalm
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sodium Chloride (nacl)
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
NASAL
</RouteName>
<StartMarketingDate>
20250328
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
M016
</ApplicationNumber>
<LabelerName>
Virexion Health Inc.
</LabelerName>
<SubstanceName>
SODIUM CHLORIDE
</SubstanceName>
<StrengthNumber>
.9
</StrengthNumber>
<StrengthUnit>
mg/100mg
</StrengthUnit>
<Pharm_Classes>
Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-04-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250328
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>